As per the agreement, Laboratorios Bago will distribute a variety of Stematix orthopedic and cellular products for use in regenerative and related medical treatments. The terms of the contract were not disclosed, but the contract also provides the option of additional forms of joint collaboration in clinical trials and treatments.
Stematix is a regenerative medicine delivery company, whose goal is to make regenerative medicine products and treatments available to patients as soon as possible, at reasonable cost and to international medical standards.
Laboratorios Bago is one of the major Argentine medical products organizations with a presence in several Latin American countries. The Bago Group comprises different companies focused on health care and on improving life quality, as well as providing high tech services in strategic areas.